Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.
Authors
Redman, J R; Cabanillas, F; Velasquez, W S; McLaughlin, P; Hagemeister, F B; Swan, F, Jr; Rodriguez, M A; Plunkett, W K; Keating, M J
Abstract
In a phase II trial we investigated fludarabine phosphate (FAMP) as therapy for patients with relapsed lymphoma to determine its effectiveness and toxicity in this disease.
Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Vol 10, Issue 5, p790